Journal Section:
Commentary
References
1.
Shields
CL
, Shields
JA
, Barrett
J
, De Potter
P
. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients
. Arch Ophthalmol
. 1995
;113
(5
):615
–23
. 2.
Jakobiec
FA
, Thanos
A
, Stagner
AM
, Grossniklaus
HE
, Proia
AD
. So-called massive retinal gliosis: a critical review and reappraisal
. Surv Ophthalmol
. 2016
;61
(3
):339
–56
. 3.
Deepak
EAC
, Eberhart
C
. WHO classification of tumours series, eye tumours [Internet]
. 2023
. Lyon (France)
; International Agency for Research on Cancer
.4.
Hegyi
L
, Peston
D
, Theodorou
M
, Moss
J
, Olver
J
, Roncaroli
F
. Primary glial tumor of the retina with features of myxopapillary ependymoma
. Am J Surg Pathol
. 2005
;29
(10
):1404
–10
. 5.
Tay
A
, Scheithauer
BW
, Cameron
JD
, Myhre
MJ
, Boerner
MJ
. Retinal ependymoma: an immunohistologic and ultrastructural study
. Hum Pathol
. 2009
;40
(4
):578
–83
. 6.
Dewan
A
, Saran
RK
, Gupta
SN
, Arya
D
, Goel
R
. Intraocular ependymoma with blood-filled spaces: neoplasm or a reactive process with ependymal differentiation-A dilemma
. Int J Surg Pathol
. 2017
;25
(4
):368
–73
. 7.
Borella
Y
, Tauziede-Espariat
A
, Gauthier
A
, Masliah-Planchon
J
, Brisse
HJ
, Matet
A
, et al. Intraocular myxo-papillary ependymoma vs retinal gliosis mimicking uveal melanoma: report of two adult patients with clinical, imaging and histopathologic features
. Ocul Oncol Pathol
. 2024
.8.
Ellison
DW
, Aldape
KD
, Capper
D
, Fouladi
M
, Gilbert
MR
, Gilbertson
RJ
, et al. cIMPACT-NOW update 7: advancing the molecular classification of ependymal tumors
. Brain Pathol
. 2020
;30
(5
):863
–6
. 9.
Pajtler
KW
, Witt
H
, Sill
M
, Jones
DT
, Hovestadt
V
, Kratochwil
F
, et al. Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups
. Cancer Cell
. 2015
;27
(5
):728
–43
. 10.
Witt
H
, Gramatzki
D
, Hentschel
B
, Pajtler
KW
, Felsberg
J
, Schackert
G
, et al. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment
. Neuro Oncol
. 2018
;20
(12
):1616
–24
. 11.
Yust Katz
S
, Cachia
D
, Kamiya-Matsuoka
C
, Olar
A
, Theeler
B
, Penas Prado
M
, et al. Ependymomas arising outside of the central nervous system: a case series and literature review
. J Clin Neurosci
. 2018
;47
:202
–7
. 12.
Drexler
R
, Brembach
F
, Sauvigny
J
, Ricklefs
FL
, Eckhardt
A
, Bode
H
, et al. Unclassifiable CNS tumors in DNA methylation-based classification: clinical challenges and prognostic impact
. Acta Neuropathol Commun
. 2024
;12
(1
):9
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended...
© 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.